Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Promoting diversity in Parkinson's research benefits every one

    Research Paper Adds Clinical Anchors to Proposed Parkinson’s Staging System

    Researchers propose adding clinical anchors to the Parkinson’s disease research framework called the Neuronal alpha-Synuclein Disease Integrated Staging System.
    Learn more
  • diversity clinical research.jpg

    Keeping a Focus on Diversity in Parkinson’s Research

    The Michael J. Fox Foundation is working toward a world without Parkinson’s disease, and diversity in research can unlock key mysteries to help us get there.
    Learn more
  • Research Podcast Cover

    Episode 24: Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen

    Dr. Judith Steen discusses her work creating novel qualitative and quantitative tools and workflows at the interface of proteomics and transcriptomics, including their novel FLEXI platform.
    Learn more
  • Doctor and two people in office

    Research Roundup: Recruiting Studies on Parkinson’s Progression and Symptoms

    The Michael J. Fox Foundation shares recruiting studies aimed at treating Parkinson’s symptoms and slowing disease progression.
    Learn more
  • Researcher-computer

    PPMI Update: Research at MDS Conference from MJFF'S Flagship Study

    Discover the latest Parkinson’s research from the Parkinson’s Progression Markers Initiative, presented at the 2024 MDS Congress on new advances in disease biomarkers and therapeutics.
    Learn more
  • Research Podcast Cover

    Episode 23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler

    Dr. Charles (Chuck) Adler shares his perspectives on how biomarkers are currently being used in clinical and research contexts, and what it would take for him to use them more often in clinical…
    Learn more
  • Three people looking at a computer screen

    FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials for Parkinson’s and Related Diseases

    FDA supports the use of alpha-synuclein seed amplification assay (αSyn-SAA) biomarker for Parkinson's clinical trials and drug development.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.